Literature DB >> 26573083

[Diagnostic workup and therapy of infectious diarrhea. Current standards].

A Stallmach1, S Hagel2,3, A W Lohse4.   

Abstract

Infectious diarrhea is very common; its severity ranges from uncomplicated, self-limiting courses to potentially life-threatening disease. A rapid diagnostic workup providing detailed information on the suspected pathogen should be performed only in patients at risk, analyzing one single stool sample for Salmonella, Shigella, Campylobacter, and Norovirus. In the presence of risk factors, such as a history of antibiotic exposure within the last 3 months, testing for Clostridium difficile should be performed. Immunocompetent patients do not require specific antibiotic therapy. Exceptions exist in patients with severe comorbidities, immunodeficiency, fever/SIRS, and in patients with Shigella or C. difficile infection. Empirical antibiotic treatment should be considered in patients with fever and/or bloody diarrhea and in patients at risk. In patients with traveler's diarrhea, microbiological diagnosis is required only in patients with fever, bloody diarrhea, prolonged course of disease (more than 5 days), severe clinical course with hypotension or dehydration, and during outbreaks. In these patients one single fecal sample should be collected for stool cultures of Campylobacter, Shigella, and Salmonella, as well as microscopic examination for amoebiasis and Giardiasis. The main therapeutic measure for infectious diarrhea is sufficient oral rehydration. As in community-acquired diarrhea, azithromycin or ciprofloxacin are recommended-taking into account local antimicrobial resistance in the country of travel and possible side effects.

Entities:  

Keywords:  Campylobacter; Clostridium difficile; Diarrhea, nosocomial; Infectious diarrheal disease; Shigella

Mesh:

Substances:

Year:  2015        PMID: 26573083     DOI: 10.1007/s00108-015-3756-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  23 in total

1.  A case of toxic megacolon secondary to Clostridium difficile-associated diarrhea worsened after administration of an antimotility agent and molecular analysis of recovered isolates.

Authors:  Hideaki Kato; Haru Kato; Makoto Nakamura; Atsushi Nakamura
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.

Authors:  L J Goodman; G M Trenholme; R L Kaplan; J Segreti; D Hines; R Petrak; J A Nelson; K W Mayer; W Landau; G W Parkhurst
Journal:  Arch Intern Med       Date:  1990-03

3.  [S2k-guideline gastrointestinal infectious diseases and Whipple's disease].

Authors:  S Hagel; H-J Epple; G E Feurle; W V Kern; P Lynen Jansen; P Malfertheiner; T Marth; E Meyer; M Mielke; V Moos; L von Müller; J Nattermann; M Nothacker; C Pox; E Reisinger; B Salzberger; H J F Salzer; M Weber; T Weinke; S Suerbaum; A W Lohse; A Stallmach
Journal:  Z Gastroenterol       Date:  2015-05-12       Impact factor: 2.000

Review 4.  Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis.

Authors:  Claudia Slimings; Thomas V Riley
Journal:  J Antimicrob Chemother       Date:  2013-12-08       Impact factor: 5.790

5.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

6.  A retrospective analysis of clinical characteristics, hospitalization, and functional outcomes in residents with and without Clostridium difficile infection in US long-term care facilities.

Authors:  Howard S Friedman; Prakash Navaratnam; Gregory Reardon; Kevin P High; Marcie E Strauss
Journal:  Curr Med Res Opin       Date:  2014-03-10       Impact factor: 2.580

7.  Ciprofloxacin and loperamide in the treatment of bacillary dysentery.

Authors:  G S Murphy; L Bodhidatta; P Echeverria; S Tansuphaswadikul; C W Hoge; S Imlarp; K Tamura
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

8.  An analysis of risk factors of Clostridiumdifficile infection in patients hospitalized in the teaching hospital in 2008.

Authors:  Grazyna Dulny; Marta Zalewska; Grazyna Mlynarczyk
Journal:  Przegl Epidemiol       Date:  2013

9.  Risk estimation for recurrent Clostridium difficile infection based on clinical factors.

Authors:  Ralph B D'Agostino; Sylva H Collins; Karol M Pencina; Yin Kean; Sherwood Gorbach
Journal:  Clin Infect Dis       Date:  2014-03-05       Impact factor: 9.079

10.  Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.

Authors:  Anu Kantele; Tinja Lääveri; Sointu Mero; Katri Vilkman; Sari H Pakkanen; Jukka Ollgren; Jenni Antikainen; Juha Kirveskari
Journal:  Clin Infect Dis       Date:  2015-01-21       Impact factor: 9.079

View more
  2 in total

Review 1.  [Gastrointestinal infections].

Authors:  C Lübbert; R Mutters
Journal:  Internist (Berl)       Date:  2017-02       Impact factor: 0.743

2.  Colloidal Silicon Dioxide in Tablet form (Carbowhite) Efficacy in Patients with Acute Diarrhea: Results of Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study.

Authors:  Vadim Tieroshyn; Larisa Moroz; Oleksandra Prishliak; Lyudmila Shostakovich-Koretska; Oksana Kruglova; Lyudmila Gordienko
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.